Ogen Related Published Studies
Research related to Ogen (Estropipate)
A bi-functional anti-thrombosis protein containing both direct-acting fibrin(ogen)olytic and plasminogen-activating activities. [2011.03.14]
A T cell-binding fragment of fibrinogen can prevent autoimmunity. [2010.06]
Suppression of the barley uroporphyrinogen III synthase gene by a Ds activation tagging element generates developmental photosensitivity. [2009.03]
Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. [2008.03]
Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. [2007.11]
Combined administration of barbourin--albumin and hirudin--albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta. [2007]
Turnover and fate of fibrinogen and platelets at the rabbit aorta wall immediately after a balloon de-endothelializing injury in vivo. [2006.07]
Fibrin(ogen) and its fragments in the pathophysiology and treatment of myocardial infarction. [2006.06]
Exogenous tissue plasminogen activator enhances peripheral nerve regeneration and functional recovery after injury in mice. [2006.01]
Snake venom fibrin(ogen)olytic enzymes. [2005.06.15]
Fibrin(ogen)olytic character of FIIa isolated from Agkistrodon acutus venom. [2005.06]
Other possibly related research studies
Differences in brain volumes among males and female hormone-therapy users and nonusers. [2006.10.30]
Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. [2006.07]
Non-clinical and clinical characterization of a novel acting thrombolytic: alfimeprase. [2005]
Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. [2006.06.01]
Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years. [2006.04.20]
Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudin. [2005]
Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects. [2005.09]
Bivalirudin: a review. [2005.07]
Alfimeprase: a novel recombinant direct-acting fibrinolytic. [2006.12]
Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosis. [2006.11]
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis. [2007.09]
Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. [2008.10]
Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper. [2008.01]
Comparison of viscoelastic coagulation analysis and standard coagulation profiles in critically ill neonatal foals to outcome. [2009.02]
Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. [2008.11]
Influence of simvastatin on microthrombosis in the brain after subarachnoid hemorrhage in rats: a preliminary study. [2010.01]
Engineering fibrin matrices: the engagement of polymerization pockets through fibrin knob technology for the delivery and retention of therapeutic proteins. [2010.03]
Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice. [2011.12]
Bioidentical hormones: an evidence-based review for primary care providers. [2011.03]
Modification of fibrin structure as a possible cause of thrombolytic resistance. [2010.04]
Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis
airway casts. [2013]
|